
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
Nanostics develops and commercializes novel, non-invasive diagnostic tests for cancer. Our core technology is an advanced liquid biopsy platform that can accurately diagnose cancer from a single drop of blood. Our lead product, ClarityDx Prostate, is the most accurate diagnostic test to diagnose aggressive prostate cancer. Go to https://www.nanosticsdx.com/clarity-dx-prostate/ to order ClarityDX Prostate today
Precision health,aggressive prostate cancer,extracellular vesicles,machine learning,microflow cytometry,high accuracy,noninvasive tests,metastatic cancer,improved patient care,diagnostic tools,high sensitivity,liquid biopsy,clinical validation,npv,auc,accurate results,metastatic blockers,and biotechnology
Nanostics inc operates in the Biotechnology research industry.
Nanostics inc's revenue is 11m - 100m
Nanostics inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.